4.7 Article

Cardiac Investigations in Sudden Unexpected Death in DEPDC5-Related Epilepsy

Journal

ANNALS OF NEUROLOGY
Volume 91, Issue 1, Pages 101-116

Publisher

WILEY
DOI: 10.1002/ana.26256

Keywords

-

Funding

  1. FRM [ANR-10- IAIHU-06, ANR-11-INBS-0011-NeurATRIS]
  2. European Research Council [682345]
  3. program Investissements d'avenir [ANR-10-IAIHU-06]
  4. Fondation pour la Recherche Medicale [FDT201904008269]
  5. National Institute for Health Research Biomedical Research Centres funding scheme
  6. National Institute for Health Research
  7. National Health Service England
  8. Wellcome Trust
  9. Cancer Research UK
  10. Medical Research Council
  11. Epilepsy Society
  12. European Research Council (ERC) [682345] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Clinical cardiac investigations in patients with pathogenic variants in DEPDC5, NPRL2, or NPRL3 did not show significant changes in cardiac function, and postmortem examination of SUDEP patients revealed no cardiac injury. Mouse models demonstrated that epileptic seizures leading to SUDEP-like events are not accompanied by cardiac arrhythmia.
Objective Germline loss-of-function mutations in DEPDC5, and in its binding partners (NPRL2/3) of the mammalian target of rapamycin (mTOR) repressor GATOR1 complex, cause focal epilepsies and increase the risk of sudden unexpected death in epilepsy (SUDEP). Here, we asked whether DEPDC5 haploinsufficiency predisposes to primary cardiac defects that could contribute to SUDEP and therefore impact the clinical management of patients at high risk of SUDEP. Methods Clinical cardiac investigations were performed in 16 patients with pathogenic variants in DEPDC5, NPRL2, or NPRL3. Two novel Depdc5 mouse strains, a human HA-tagged Depdc5 strain and a Depdc5 heterozygous knockout with a neuron-specific deletion of the second allele (Depdc5(c/-)), were generated to investigate the role of Depdc5 in SUDEP and cardiac activity during seizures. Results Holter, echocardiographic, and electrocardiographic (ECG) examinations provided no evidence for altered clinical cardiac function in the patient cohort, of whom 3 DEPDC5 patients succumbed to SUDEP and 6 had a family history of SUDEP. There was no cardiac injury at autopsy in a postmortem DEPDC5 SUDEP case. The HA-tagged Depdc5 mouse revealed expression of Depdc5 in the brain, heart, and lungs. Simultaneous electroencephalographic-ECG records on Depdc5(c/-) mice showed that spontaneous epileptic seizures resulting in a SUDEP-like event are not preceded by cardiac arrhythmia. Interpretation Mouse and human data show neither structural nor functional cardiac damage that might underlie a primary contribution to SUDEP in the spectrum of DEPDC5-related epilepsies. ANN NEUROL 2021

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available